Veracyte PE Ratio 2012-2023 | VCYT
Current and historical p/e ratio for Veracyte (VCYT) from 2012 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veracyte PE ratio as of April 26, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Veracyte PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-26 | 19.31 | 0.00 | |
| 2023-12-31 | 27.51 | $-1.03 | 0.00 |
| 2023-09-30 | 22.33 | $-0.69 | 0.00 |
| 2023-06-30 | 25.47 | $-0.40 | 0.00 |
| 2023-03-31 | 22.30 | $-0.41 | 0.00 |
| 2022-12-31 | 23.73 | $-0.50 | 0.00 |
| 2022-09-30 | 16.60 | $-0.60 | 0.00 |
| 2022-06-30 | 19.90 | $-0.68 | 0.00 |
| 2022-03-31 | 27.57 | $-0.68 | 0.00 |
| 2021-12-31 | 41.20 | $-1.14 | 0.00 |
| 2021-09-30 | 46.45 | $-1.13 | 0.00 |
| 2021-06-30 | 39.98 | $-1.01 | 0.00 |
| 2021-03-31 | 53.75 | $-1.10 | 0.00 |
| 2020-12-31 | 48.94 | $-0.68 | 0.00 |
| 2020-09-30 | 32.49 | $-0.69 | 0.00 |
| 2020-06-30 | 25.90 | $-0.63 | 0.00 |
| 2020-03-31 | 24.31 | $-0.46 | 0.00 |
| 2019-12-31 | 27.92 | $-0.27 | 0.00 |
| 2019-09-30 | 24.00 | $-0.20 | 0.00 |
| 2019-06-30 | 28.51 | $-0.30 | 0.00 |
| 2019-03-31 | 25.02 | $-0.43 | 0.00 |
| 2018-12-31 | 12.58 | $-0.65 | 0.00 |
| 2018-09-30 | 9.55 | $-0.81 | 0.00 |
| 2018-06-30 | 9.34 | $-0.90 | 0.00 |
| 2018-03-31 | 5.56 | $-0.94 | 0.00 |
| 2017-12-31 | 6.53 | $-0.91 | 0.00 |
| 2017-09-30 | 8.77 | $-0.81 | 0.00 |
| 2017-06-30 | 8.33 | $-0.80 | 0.00 |
| 2017-03-31 | 9.18 | $-0.98 | 0.00 |
| 2016-12-31 | 7.74 | $-1.10 | 0.00 |
| 2016-09-30 | 7.61 | $-1.25 | 0.00 |
| 2016-06-30 | 5.03 | $-1.37 | 0.00 |
| 2016-03-31 | 5.40 | $-1.31 | 0.00 |
| 2015-12-31 | 7.20 | $-1.31 | 0.00 |
| 2015-09-30 | 4.69 | $-1.39 | 0.00 |
| 2015-03-31 | 7.28 | $-1.38 | 0.00 |
| 2014-12-31 | 9.66 | $-1.36 | 0.00 |
| 2014-09-30 | 9.75 | $-1.42 | 0.00 |
| 2014-06-30 | 17.12 | $-1.40 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.450B | $0.361B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.951B | 26.53 |
| Intuitive Surgical (ISRG) | United States | $133.132B | 80.20 |
| Edwards Lifesciences (EW) | United States | $52.025B | 33.89 |
| DexCom (DXCM) | United States | $49.242B | 74.90 |
| IQVIA Holdings (IQV) | United States | $42.631B | 25.28 |
| IDEXX Laboratories (IDXX) | United States | $41.469B | 49.58 |
| Alcon (ALC) | Switzerland | $38.841B | 28.64 |
| STERIS (STE) | Ireland | $20.148B | 23.85 |
| Waters (WAT) | United States | $18.463B | 26.49 |
| Hologic (HOLX) | United States | $17.835B | 19.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.800B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.341B | 85.27 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.795B | 14.57 |
| Sysmex ADR (SSMXY) | Japan | $10.000B | 31.36 |
| Teleflex (TFX) | United States | $9.736B | 15.29 |
| Penumbra (PEN) | United States | $7.923B | 97.80 |
| Masimo (MASI) | United States | $7.204B | 40.40 |
| Globus Medical (GMED) | United States | $6.843B | 21.70 |
| Glaukos (GKOS) | United States | $4.993B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.671B | 22.18 |
| TransMedics (TMDX) | United States | $3.012B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.996B | 19.76 |
| PROCEPT BioRobotics (PRCT) | United States | $2.664B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.629B | 18.04 |
| Nihon Kohden (NHNKY) | Japan | $2.417B | 20.44 |
| Tandem Diabetes Care (TNDM) | United States | $2.275B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.228B | 9.14 |
| Inari Medical (NARI) | United States | $2.227B | 384.20 |
| RxSight (RXST) | United States | $1.952B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.716B | 0.00 |
| OPKO Health (OPK) | United States | $0.878B | 0.00 |
| Artivion (AORT) | United States | $0.847B | 97.95 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.836B | 15.47 |
| Paragon 28 (FNA) | United States | $0.730B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.720B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.697B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.642B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.557B | 18.90 |
| IRadimed (IRMD) | United States | $0.530B | 30.78 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Nevro (NVRO) | United States | $0.415B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.397B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| NeuroPace (NPCE) | United States | $0.385B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.340B | 11.44 |
| CVRx (CVRX) | United States | $0.317B | 0.00 |
| AxoGen (AXGN) | United States | $0.290B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.270B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.233B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.89 |
| Alpha Tau Medical (DRTS) | Israel | $0.168B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.142B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.135B | 0.00 |
| Neuronetics (STIM) | United States | $0.105B | 0.00 |
| Envoy Medical (COCH) | United States | $0.102B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.67 |
| Vasomedical (VASO) | United States | $0.053B | 9.47 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.041B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |